Texas 2015 - 84th Regular

Texas Senate Bill SB172 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	By: Huffman, et al. S.B. No. 172
2		-	(Clardy, Herrero)
	1	+	S.B. No. 172
3	2
4	3
5		-	A BILL TO BE ENTITLED
6	4		AN ACT
7	5		relating to the addition of certain substances to Penalty Groups
8	6		1-A and 2 of the Texas Controlled Substances Act for criminal
9	7		prosecution and other purposes.
10	8		BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
11	9		SECTION 1. Section 481.002(50), Health and Safety Code, is
12	10		amended to read as follows:
13	11		(50) "Abuse unit" means:
14	12		(A) except as provided by Paragraph (B):
15	13		(i) a single unit on or in any adulterant,
16	14		dilutant, or similar carrier medium, including marked or perforated
17	15		blotter paper, a tablet, gelatin wafer, sugar cube, or stamp, or
18	16		other medium that contains any amount of a controlled substance
19	17		listed in Penalty Group 1-A, if the unit is commonly used in abuse
20	18		of that substance; or
21	19		(ii) each quarter-inch square section of
22	20		paper, if the adulterant, dilutant, or carrier medium is paper not
23	21		marked or perforated into individual abuse units; or
24	22		(B) if the controlled substance is in liquid or
25	23		solid form, 40 micrograms of the controlled substance including any
26	24		adulterant or dilutant.
27	25		SECTION 2. Section 481.1021, Health and Safety Code, is
28	26		amended to read as follows:
29	27		Sec. 481.1021. PENALTY GROUP 1-A. (a) Penalty Group 1-A
30	28		consists of:
31	29		(1) lysergic acid diethylamide (LSD), including its
32	30		salts, isomers, and salts of isomers; and
33	31		(2) compounds structurally derived from
34	32		2,5-dimethoxyphenethylamine by substitution at the 1-amino
35	33		nitrogen atom with a benzyl substituent, including:
36	34		(A) compounds further modified by:
37	35		(i) substitution in the phenethylamine ring
38	36		at the 4-position to any extent (including alkyl, alkoxy,
39	37		alkylenedioxy, haloalkyl, or halide substituents); or
40	38		(ii) substitution in the benzyl ring to any
41	39		extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
42	40		halide substituents); and
43	41		(B) by example, compounds such as:
44	42		4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl)
45	43		phenethylamine (trade or other names: 25B-NBOMe, 2C-B-NBOMe);
46	44		4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)
47	45		phenethylamine (trade or other names: 25C-NBOMe, 2C-C-NBOMe);
48	46		2,5-Dimethoxy-4-methyl-N-(2-methoxybenzyl)
49	47		phenethylamine (trade or other names: 25D-NBOMe, 2C-D-NBOMe);
50	48		4-Ethyl-2,5-dimethoxy-N-(2-methoxybenzyl)
51	49		phenethylamine (trade or other names: 25E-NBOMe, 2C-E-NBOMe);
52	50		2,5-Dimethoxy-N-(2-
53	51		methoxybenzyl)phenethylamine (some trade and other names:
54	52		25H-NBOMe, 2C-H-NBOMe);
55	53		4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)
56	54		phenethylamine (some trade and other names: 25I-NBOMe,
57	55		2C-I-NBOMe);
58	56		4-Iodo-2,5-dimethoxy-N-
59	57		benzylphenethylamine (trade or other name: 25I-NB);
60	58		4-Iodo-2,5-dimethoxy-N-(2,3-
61	59		methylenedioxybenzyl)phenethylamine (trade or other name:
62	60		25I-NBMD);
63	61		4-Iodo-2,5-dimethoxy-N-(2-
64	62		fluorobenzyl)phenethylamine (trade or other name: 25I-NBF);
65	63		4-Iodo-2,5-dimethoxy-N-(2-hydroxybenzyl)
66	64		phenethylamine (trade or other name: 25I-NBOH);
67	65		2,5-Dimethoxy-4-nitro-N-(2-methoxybenzyl)
68	66		phenethylamine (trade or other names: 25N-NBOMe, 2C-N-NBOMe); and
69	67		2,5-Dimethoxy-4-(n)-propyl-N-(2-
70	68		methoxybenzyl)phenethylamine (some trade and other names:
71	69		25P-NBOMe, 2C-P-NBOMe).
72	70		(b) To the extent Subsection (a)(2) conflicts with another
73	71		provision of this subtitle or another law, the other provision or
74	72		the other law prevails.
75	73		SECTION 3. Section 481.103, Health and Safety Code, is
76	74		amended by amending Subsections (a) and (c) and adding Subsection
77	75		(d) to read as follows:
78	76		(a) Penalty Group 2 consists of:
79	77		(1) any quantity of the following hallucinogenic
80	78		substances, their salts, isomers, and salts of isomers, unless
81	79		specifically excepted, if the existence of these salts, isomers,
82	80		and salts of isomers is possible within the specific chemical
83	81		designation:
84	82		5-(2-aminopropyl)benzofuran (5-APB);
85	83		6-(2-aminopropyl)benzofuran (6-APB);
86	84		5-(2-aminopropyl)-2,3-dihydrobenzofuran
87	85		(5-APDB);
88	86		6-(2-aminopropyl)-2,3-dihydrobenzofuran
89	87		(6-APDB);
90	88		5-(2-aminopropyl)indole (5-IT,5-API);
91	89		6-(2-aminopropyl)indole (6-IT,6-API);
92	90		1-(benzofuran-5-yl)-N-methylpropan-2-amine
93	91		(5-MAPB);
94	92		1-(benzofuran-6-yl)-N-methylpropan-2-amine
95	93		(6-MAPB);
96	94		Benzothiophenylcyclohexylpiperidine (BTCP);
97	95		8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
98	96		4-ethanamine (trade or other name: Bromo-DragonFLY);
99	97		Desoxypipradrol (2-benzhydrylpiperidine);
100	98		[alpha-ethyltryptamine;
101	99		[alpha-methyltryptamine;
102	100		[4-bromo-2, 5-dimethoxyamphetamine (some trade or
103	101		other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
104	102		4-bromo-2, 5-DMA);
105	103		[4-bromo-2, 5-dimethoxyphenethylamine;
106	104		[Bufotenine (some trade and other
107	105		names: 3-(beta- Dimethylaminoethyl)-5-hydroxyindole;
108	106		3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
109	107		5-hydroxy-N, N- dimethyltryptamine; mappine);
110	108		[Diethyltryptamine (some trade and other
111	109		names: N, N-Diethyltryptamine, DET);]
112	110		2, 5-dimethoxyamphetamine (some trade or other
113	111		names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
114	112		Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
115	113		methanol, D2PM);
116	114		[2, 5-dimethoxy-4-ethylamphetamine (trade or
117	115		other name: DOET);
118	116		[2, 5-dimethoxy-4-(n)-propylthiophenethylamine
119	117		(trade or other name: 2C-T-7);
120	118		[Dimethyltryptamine (trade or other name: DMT);]
121	119		Dronabinol (synthetic) in sesame oil and
122	120		encapsulated in a soft gelatin capsule in a U.S. Food and Drug
123	121		Administration approved drug product (some trade or other names for
124	122		Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
125	123		trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
126	124		(trans)- tetrahydrocannabinol);
127	125		Ethylamine Analog of Phencyclidine (some trade or
128	126		other names: N-ethyl-1-phenylcyclohexylamine, (1-
129	127		phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
130	128		cyclohexamine, PCE);
131	129		2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
132	130		(trade or other name: methoxetamine);
133	131		Ibogaine (some trade or other names: 7-Ethyl-6,
134	132		6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
135	133		pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
136	134		5-iodo-2-aminoindane (5-IAI);
137	135		Mescaline;
138	136		[5-methoxy-N, N-diisopropyltryptamine;]
139	137		5-methoxy-3, 4-methylenedioxy amphetamine;
140	138		4-methoxyamphetamine (some trade or other
141	139		names: 4-methoxy-alpha-methylphenethylamine;
142	140		paramethoxyamphetamine; PMA);
143	141		4-methoxymethamphetamine (PMMA);
144	142		2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
145	143		(some trade and other names: 2-MeO-ketamine; methoxyketamine);
146	144		1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
147	145		PPMP);
148	146		4-methyl-2, 5-dimethoxyamphetamine (some trade
149	147		and other names: 4-methyl-2, 5-dimethoxy-alpha-
150	148		methylphenethylamine; "DOM"; "STP");
151	149		3,4-methylenedioxy methamphetamine (MDMA, MDM);
152	150		3,4-methylenedioxy amphetamine;
153	151		3,4-methylenedioxy N-ethylamphetamine (Also
154	152		known as N-ethyl MDA);
155	153		5,6-methylenedioxy-2-aminoindane (MDAI);
156	154		Nabilone (Another name for nabilone: (+)-trans-
157	155		3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
158	156		6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
159	157		N-benzylpiperazine (some trade or other
160	158		names: BZP; 1-benzylpiperazine);
161	159		N-ethyl-3-piperidyl benzilate;
162	160		N-hydroxy-3,4-methylenedioxyamphetamine (Also
163	161		known as N-hydroxy MDA);
164	162		4-methylaminorex;
165	163		N-methyl-3-piperidyl benzilate;
166	164		Parahexyl (some trade or other names: 3-Hexyl-1-
167	165		hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
168	166		pyran; Synhexyl);
169	167		1-Phenylcyclohexylamine;
170	168		1-Piperidinocyclohexanecarbonitrile (PCC);
171	169		[Psilocin;
172	170		[Psilocybin;]
173	171		Pyrrolidine Analog of Phencyclidine (some trade
174	172		or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
175	173		Tetrahydrocannabinols, other than marihuana, and
176	174		synthetic equivalents of the substances contained in the plant, or
177	175		in the resinous extractives of Cannabis, or synthetic substances,
178	176		derivatives, and their isomers with similar chemical structure and
179	177		pharmacological activity such as:
180	178		delta-1 cis or trans tetrahydrocannabinol,
181	179		and their optical isomers;
182	180		delta-6 cis or trans tetrahydrocannabinol,
183	181		and their optical isomers;
184	182		delta-3, 4 cis or trans
185	183		tetrahydrocannabinol, and its optical isomers; or
186	184		compounds of these structures, regardless of
187	185		numerical designation of atomic positions, since nomenclature of
188	186		these substances is not internationally standardized;
189	187		Thiophene Analog of Phencyclidine (some trade or
190	188		other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
191	189		Analog of Phencyclidine; TPCP, TCP);
192	190		1-pyrrolidine (some trade or other name: TCPy);
193	191		1-(3-trifluoromethylphenyl)piperazine (trade or
194	192		other name: TFMPP); and
195	193		3,4,5-trimethoxy amphetamine;
196	194		(2) Phenylacetone (some trade or other
197	195		names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
198	196		ketone);
199	197		(3) unless specifically excepted or unless listed in
200	198		another Penalty Group, a material, compound, mixture, or
201	199		preparation that contains any quantity of the following substances
202	200		having a potential for abuse associated with a depressant or
203	201		stimulant effect on the central nervous system:
204	202		Aminorex (some trade or other
205	203		names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
206	204		phenyl-2-oxazolamine);
207	205		Amphetamine, its salts, optical isomers, and
208	206		salts of optical isomers;
209	207		Cathinone (some trade or other names: 2-amino-1-
210	208		phenyl-1-propanone, alpha-aminopropiophenone, 2-
211	209		aminopropiophenone);
212	210		Etaqualone and its salts;
213	211		Etorphine Hydrochloride;
214	212		Fenethylline and its salts;
215	213		Lisdexamfetamine, including its salts, isomers,
216	214		and salts of isomers;
217	215		Mecloqualone and its salts;
218	216		Methaqualone and its salts;
219	217		Methcathinone (some trade or other names: 2-
220	218		methylamino-propiophenone; alpha-(methylamino)propriophenone;
221	219		2-(methylamino)-1-phenylpropan-1-one; alpha-N-
222	220		methylaminopropriophenone; monomethylpropion; ephedrone, N-
223	221		methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
224	222		1431);
225	223		N-Ethylamphetamine, its salts, optical isomers,
226	224		and salts of optical isomers; and
227	225		N,N-dimethylamphetamine (some trade or other
228	226		names: N,N,alpha-trimethylbenzeneethanamine
229	227		[N,N,alpha-trimethylbenzeneethaneamine];
230	228		N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
231	229		and salts of optical isomers; [and]
232	230		(4) any compound structurally derived from
233	231		2-aminopropanal by substitution at the 1-position with any
234	232		monocyclic or fused-polycyclic ring system, including:
235	233		(A) compounds further modified by:
236	234		(i) substitution in the ring system to any
237	235		extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
238	236		halide substituents), whether or not further substituted in the
239	237		ring system by other substituents;
240	238		(ii) substitution at the 3-position with an
241	239		alkyl substituent; or
242	240		(iii) substitution at the 2-amino nitrogen
243	241		atom with alkyl, benzyl, [or] dialkyl, or methoxybenzyl groups, or
244	242		inclusion of the 2-amino nitrogen atom in a cyclic structure; and
245	243		(B) by example, compounds such as:
246	244		4-Methylmethcathinone (Also known as
247	245		Mephedrone);
248	246		3,4-Dimethylmethcathinone (Also known as
249	247		3,4-DMMC);
250	248		3-Fluoromethcathinone (Also known as 3-FMC);
251	249		4-Fluoromethcathinone (Also known as
252	250		Flephedrone);
253	251		3,4-Methylenedioxy-N-methylcathinone (Also
254	252		known as Methylone);
255	253		3,4-Methylenedioxypyrovalerone (Also known
256	254		as MDPV);
257	255		alpha-Pyrrolidinopentiophenone (Also known
258	256		as alpha-PVP);
259	257		Naphthylpyrovalerone (Also known as
260	258		Naphyrone);
261	259		alpha-Methylamino-valerophenone (Also known
262	260		as Pentedrone);
263	261		beta-Keto-N-methylbenzodioxolylpropylamine
264	262		(Also known as Butylone);
265	263		beta-Keto-N-methylbenzodioxolylpentanamine
266	264		(Also known as Pentylone);
267	265		beta-Keto-Ethylbenzodioxolylbutanamine
268	266		(Also known as Eutylone); and
269	267		3,4-methylenedioxy-N-ethylcathinone (Also
270	268		known as Ethylone);
271	269		(5) any compound structurally derived from tryptamine
272	270		(3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:
273	271		(A) by modification in any of the following ways:
274	272		(i) by substitution at the amine nitrogen
275	273		atom of the sidechain to any extent with alkyl or alkenyl groups or
276	274		by inclusion of the amine nitrogen atom of the side chain (and no
277	275		other atoms of the side chain) in a cyclic structure;
278	276		(ii) by substitution at the carbon atom
279	277		adjacent to the nitrogen atom of the side chain (alpha-position)
280	278		with an alkyl or alkenyl group;
281	279		(iii) by substitution in the 6-membered
282	280		ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl,
283	281		alkylenedioxy, or halide substituents; or
284	282		(iv) by substitution at the 2-position of
285	283		the tryptamine ring system with an alkyl substituent; and
286	284		(B) including:
287	285		(i) ethers and esters of the controlled
288	286		substances listed in this subdivision; and
289	287		(ii) by example, compounds such as:
290	288		alpha-ethyltryptamine;
291	289		alpha-methyltryptamine;
292	290		Bufotenine (some trade and other names:
293	291		3-(beta-Dimethylaminoethyl)-5-hydroxyindole;
294	292		3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
295	293		5-hydroxy-N, N- dimethyltryptamine; mappine);
296	294		Diethyltryptamine (some trade and
297	295		other names: N, N-Diethyltryptamine, DET);
298	296		Dimethyltryptamine (trade or other
299	297		name: DMT);
300	298		5-methoxy-N, N-diisopropyltryptamine
301	299		(5-MeO-DiPT);
302	300		O-Acetylpsilocin (Trade or other name:
303	301		4-Aco-DMT);
304	302		Psilocin; and
305	303		Psilocybin;
306	304		(6) 2,5-Dimethoxyphenethylamine and any compound
307	305		structurally derived from 2,5-Dimethoxyphenethylamine by
308	306		substitution at the 4-position of the phenyl ring to any extent
309	307		(including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide
310	308		substituents), including, by example, compounds such as:
311	309		4-Bromo-2,5-dimethoxyphenethylamine (trade or
312	310		other name: 2C-B);
313	311		4-Chloro-2,5-dimethoxyphenethylamine (trade or
314	312		other name: 2C-C);
315	313		2,5-Dimethoxy-4-methylphenethylamine (trade or
316	314		other name: 2C-D);
317	315		4-Ethyl-2,5-dimethoxyphenethylamine (trade or
318	316		other name: 2C-E);
319	317		4-Iodo-2,5-dimethoxyphenethylamine (trade or
320	318		other name: 2C-I);
321	319		2,5-Dimethoxy-4-nitrophenethylamine (trade or
322	320		other name: 2C-N);
323	321		2,5-Dimethoxy-4-(n)-propylphenethylamine (trade
324	322		or other name: 2C-P);
325	323		4-Ethylthio-2,5-dimethoxyphenethylamine (trade
326	324		or other name: 2C-T-2);
327	325		4-Isopropylthio-2,5-dimethoxyphenethylamine
328	326		(trade or other name: 2C-T-4); and
329	327		2,5-Dimethoxy-4-(n)-propylthiophenethylamine
330	328		(trade or other name: 2C-T-7); and
331	329		(7) 2,5-Dimethoxyamphetamine and any compound
332	330		structurally derived from 2,5-Dimethoxyamphetamine by substitution
333	331		at the 4-position of the phenyl ring to any extent (including alkyl,
334	332		alkoxy, alkylenedioxy, haloalkyl, or halide substituents),
335	333		including, by example, compounds such as:
336	334		4-Ethylthio-2,5-dimethoxyamphetamine (trade or
337	335		other name: Aleph-2);
338	336		4-Isopropylthio-2,5-dimethoxyamphetamine (trade
339	337		or other name: Aleph-4);
340	338		4-Bromo-2,5-dimethoxyamphetamine (trade or other
341	339		name: DOB);
342	340		4-Chloro-2,5-dimethoxyamphetamine (trade or
343	341		other name: DOC);
344	342		2,5-Dimethoxy-4-ethylamphetamine (trade or other
345	343		name: DOET);
346	344		4-Iodo-2,5-dimethoxyamphetamine (trade or other
347	345		name: DOI);
348	346		2,5-Dimethoxy-4-methylamphetamine (trade or
349	347		other name: DOM);
350	348		2,5-Dimethoxy-4-nitroamphetamine (trade or other
351	349		name: DON);
352	350		4-Isopropyl-2,5-dimethoxyamphetamine (trade or
353	351		other name: DOIP); and
354	352		2,5-Dimethoxy-4-(n)-propylamphetamine (trade or
355	353		other name: DOPR).
356	354		(c) To the extent Subsection (a)(4), (5), (6), or (7)
357	355		conflicts with another provision or this subtitle or another law,
358	356		the other provision [subtitle] or the other law prevails. If a
359	357		substance listed in this section is also listed in another penalty
360	358		group, the listing in the other penalty group controls.
361	359		(d) If a substance listed in this section is approved by the
362	360		Federal Drug Administration, the inclusion of that substance in
363	361		this penalty group does not apply, and notwithstanding any other
364	362		law, a person may not be convicted for the manufacture or delivery
365	363		of the substance under Section 481.113 or for possession of the
366	364		substance under Section 481.116.
367	365		SECTION 4. The change in law made by this Act applies only
368	366		to an offense committed on or after the effective date of this Act.
369	367		An offense committed before the effective date of this Act is
370	368		governed by the law in effect on the date the offense was committed,
371	369		and the former law is continued in effect for that purpose. For
372	370		purposes of this section, an offense was committed before the
373	371		effective date of this Act if any element of the offense occurred
374	372		before that date.
375	373		SECTION 5. This Act takes effect September 1, 2015.
	374	+	______________________________ ______________________________
	375	+	President of the Senate Speaker of the House
	376	+	I hereby certify that S.B. No. 172 passed the Senate on
	377	+	March 24, 2015, by the following vote: Yeas 31, Nays 0.
	378	+	______________________________
	379	+	Secretary of the Senate
	380	+	I hereby certify that S.B. No. 172 passed the House on
	381	+	May 11, 2015, by the following vote: Yeas 136, Nays 1, one
	382	+	present not voting.
	383	+	______________________________
	384	+	Chief Clerk of the House
	385	+	Approved:
	386	+	______________________________
	387	+	Date
	388	+	______________________________
	389	+	Governor